Hints and tips:
...Similarly, How We Age by Coleen T Murphy, director of Princeton University’s Paul F Glenn Laboratories for Aging Research, provides a lucid and detailed overview of the field for a more advanced readership...
...The Omicron variant is now dominant in the US, according to the Centers for Disease Control and Prevention, accounting for 73 per cent of sequenced cases, up from 13 per cent in the previous week....
...Abortion restrictions have “real, concrete impacts” on women’s lives, said C Nicole Mason, chief executive of the Institute for Women’s Policy Research....
...The lesson is that, whatever the downturn faced by the UK this year, a realistically funded, Green New Deal-type programme is the best medicine for turning the economy around, levelling up and preparing...
..., said Peter Hotez, co-director of the Center for Vaccine Development at Texas Children’s Hospital....
...“They increased the tempo of their naval activity quite a bit to keep the Chinese on their toes,” said Curtis, head of the Indo-Pacific Security Program at the Center for a New American Security....
...The US Centers for Disease Control and Prevention says that “dietary supplements aren’t meant to treat or prevent Covid-19” but adds that certain vitamins and minerals, such as vitamins C and D and zinc,...
...Mr Biden’s plans bolster support for nuclear. The president-elect has proposed creating a new research agency, ARPA-C, to help develop SMRs and iron out other issues with nuclear....
...We also show the “true” trough P/E (i.e. with perfect foresight for actual earnings, not forecast). This tends to be c.20% higher....
...above pre-industrial levels and pursuing efforts to limit the temperature increase to 1.5°C’.”...
...The US Centers for Disease Control believes there are roughly 20,000 fatalities each year from chronic liver disease or cirrhosis that are not related to alcoholism....
...In comparison, the total return index for speculative-rated US bonds, which carry a rating below triple-B minus, advanced by about 0.5 per cent over the same time horizon....
...(Lancet) Hep C gaps The EU, with its advanced healthcare systems, is uniquely poised to eliminate hepatitis C....
...Yet, two years later, GSK is once again training its sights on the “big C”....
...cancer, heart disease and hepatitis C....
...A wave of new multibillion-dollar medicines for heart disease and high cholesterol, added to recent breakthroughs in cancer and hepatitis C, is reviving optimism that the pharmaceuticals industry has moved...
...Earlier this month, the US Centers for Disease Control and Prevention said heroin use had increased by 63 per cent between 2002 and 2013 across the US, especially among women, people with private insurance...
...The productivity growth rate of US hospitals has been underestimated by the official data, which fail to properly adjust for the severity of patient illness, according to a study by John A Romley, Dana P...
...Access to the most advanced oncology medicines in the developing world has so far been limited....
...Standard-bearer for this latter group is Gilead Sciences, whose hepatitis C medicine, Sovaldi, broke industry records in 2014 by generating about $10bn of sales in its first year. 2014 deals: Merck bought...
...‘Not amazing enough’ Genomic science is producing revolutionary new drugs, from a cure for hepatitis-C to immunotherapy treatments....
...The FTSE All-World equity index added 0.9 per cent and the FTSE Eurofirst advanced 0.9 per cent. Milan’s FTSE MIB index recovered early losses to close higher on the day....
...That said, McKinsey has for many decades also looked for top talent from many different sources including other advanced degree programmes (engineering, medicine, law, science, humanities, etc.) as well...
...Vernalis , a lossmaking UK biotech company, jumped 29.5 per cent to 25¼p after announcing a deal with privately owned Tris Pharma to develop up to six “novel formulations” of existing medicines for the US...
...C&W Communications, whose maiden results since demerger disappointed earlier in the week, bounced 5.7 per cent to 49½p after its communications director bought 1m shares....
International Edition